chr1-186680587-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000680451.1(PTGS2):​c.-114+117C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00616 in 406,366 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.012 ( 36 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 11 hom. )

Consequence

PTGS2
ENST00000680451.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.302

Publications

17 publications found
Variant links:
Genes affected
PTGS2 (HGNC:9605): (prostaglandin-endoperoxide synthase 2) Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009]
PACERR (HGNC:50552): (PTGS2 antisense NFKB1 complex-mediated expression regulator RNA) This gene represents transcription of a long non-coding RNA produced in antisense to the prostaglandin-endoperoxide synthase 2 (PTGS2) gene. This transcript interacts with NF-kB transcriptional regulators to promote expression of PTGS2. [provided by RefSeq, Feb 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0121 (1838/152250) while in subpopulation AFR AF = 0.0416 (1727/41548). AF 95% confidence interval is 0.0399. There are 36 homozygotes in GnomAd4. There are 874 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1838 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000680451.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTGS2
NM_000963.4
MANE Select
c.-297C>G
upstream_gene
N/ANP_000954.1P35354
PACERR
NR_125801.1
n.-67G>C
upstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTGS2
ENST00000680451.1
c.-114+117C>G
intron
N/AENSP00000506242.1P35354
PACERR
ENST00000608917.4
TSL:6
n.480G>C
non_coding_transcript_exon
Exon 1 of 1
PTGS2
ENST00000367468.10
TSL:1 MANE Select
c.-297C>G
upstream_gene
N/AENSP00000356438.5P35354

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1831
AN:
152132
Hom.:
36
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0415
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00445
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00424
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00670
GnomAD4 exome
AF:
0.00262
AC:
667
AN:
254116
Hom.:
11
Cov.:
0
AF XY:
0.00240
AC XY:
316
AN XY:
131674
show subpopulations
African (AFR)
AF:
0.0451
AC:
296
AN:
6570
American (AMR)
AF:
0.00238
AC:
21
AN:
8822
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8940
East Asian (EAS)
AF:
0.0133
AC:
263
AN:
19718
South Asian (SAS)
AF:
0.000265
AC:
4
AN:
15096
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
19198
Middle Eastern (MID)
AF:
0.000779
AC:
1
AN:
1284
European-Non Finnish (NFE)
AF:
0.0000504
AC:
8
AN:
158604
Other (OTH)
AF:
0.00466
AC:
74
AN:
15884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
31
63
94
126
157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0121
AC:
1838
AN:
152250
Hom.:
36
Cov.:
32
AF XY:
0.0117
AC XY:
874
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0416
AC:
1727
AN:
41548
American (AMR)
AF:
0.00445
AC:
68
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00425
AC:
22
AN:
5178
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68024
Other (OTH)
AF:
0.00664
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00895
Hom.:
1
Bravo
AF:
0.0142
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
7.1
DANN
Benign
0.50
PhyloP100
0.30
PromoterAI
-0.24
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5270; hg19: chr1-186649719; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.